DNAJA1 and cancer: The mechanism of action appears to be through the inhibition of DNAJA1 farnesylation and destruction of mutant p53.46, 48 Given the challenges of inhibiting chaperones in cancer, manipulating co-chaperone PTMs may offer novel therapeutic strategies to investigate.